Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients

JACC: Cardiovascular Imaging

Volumn 7, Issue 9, 2014, Pages 930-939

  Van Kranenburg, Matthijs ^a   Magro, Michael ^a   Thiele, Holger ^b   DeWaha, Suzanne ^c   Eitel, Ingo ^b   Cochet, Alexandre ^d   Cottin, Yves ^e   Atar, Dan ^f   Buser, Peter ^g   Wu, Edwin ^h   Lee, Daniel ^h   Bodi, Vicente ⁱ   Klug, Gert ^j   Metzler, Bernhard ^j   Delewi, Ronak ^k   Bernhardt, Peter ^l   Rottbauer, Wolfgang ^l   Boersma, Eric ^a   Zijlstra, Felix ^a   Van Geuns, Robert Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Heart Center Bad Segeberg   (Germany)

^d CENTRE GEORGES FRANÇOIS LECLERC   (France)

^e DIJON UNIVERSITY HOSPITAL   (France)

^f ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF VALENCIA   (Spain)

^j INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^k ACADEMIC MEDICAL CENTER   (Netherlands)

^l UNIVERSITY OF ULM   (Germany)

more..

Author keywords

Cardiac magnetic resonance; Infarct size; Microvascular obstruction; Myocardial infarction; Prognosis

Indexed keywords

ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CONGESTIVE HEART FAILURE; HEART DEATH; HEART DISEASE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE MASS; HUMAN; MICROANGIOPATHY; MICROVASCULAR OBSTRUCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADVERSE EFFECTS; AGED; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART FAILURE; HEART MUSCLE; HEART VENTRICLE; MALE; META ANALYSIS; MICROCIRCULATION; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; NO-REFLOW PHENOMENON; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; CORONARY CIRCULATION; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NO-REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE OF TESTS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84922606455     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2014.05.010     Document Type: Review

References (28)

1. Steg PG, James SK, Atar D, et al., Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33: 2569-619.
2. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009;54:281-92.
3. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54: 1496-508.
4. Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G. Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol 2006;47:1641-5.
5. Baks T, van Geuns RJ, Biagini E, et al. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics. J Am Coll Cardiol 2006;47:40-4.
6. Nijveldt R, Beek AM, Hirsch A, et al. Functional recovery after acute myocardial infarction: comparison between angiography, electrocardiography, and cardiovascular magnetic resonance measures of microvascular injury. J Am Coll Cardiol 2008;52:181-9.
7. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-72.
8. Hombach V, Grebe O, Merkle N, et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005;26:549-57.
9. Wu E, Ortiz JT, Tejedor P, et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 2008; 94:730-6.
10. Bodi V, Sanchis J, Nunez J, et al. Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction. J Am Coll Cardiol Img 2009;2:835-42.
11. Cochet AA, Lorgis L, Lalande A, et al. Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction. Eur Radiol 2009;19: 2117-26.
12. de Waha S, Desch S, Eitel I, et al. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J 2010;31:2660-8.
13. Klug G, Mayr A, Schenk S, et al. Prognostic value at 5 years of microvascular obstruction after acute myocardial infarction assessed by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14:46.
14. Larose E, Rodes-Cabau J, Pibarot P, et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol 2010;55:2459-69.
15. Halkin A, Singh M, Nikolsky E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score. J Am Coll Cardiol 2005;45: 1397-405.
16. De Luca G, Suryapranata H, van't Hof AW, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: implications for early discharge. Circulation 2004;109:2737-43.
17. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000;102:2031-7.
18. Atar D, Petzelbauer P, Schwitter J, et al. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial. J Am Coll Cardiol 2009;53:720-9.
19. Hirsch A, Nijveldt R, van der Vleuten PA, et al. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. Eur Heart J 2011;32: 1736-47.
20. Harrell FE Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15: 361-87.
21. Ott I, Schulz S, Mehilli J, et al. Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial. Circ Cardiovasc Interv 2010;3: 408-13.
22. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
23. Eitel I, Wohrle J, Suenkel H, et al. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. J Am Coll Cardiol 2013;61:1447-54.
24. Riley RD, Lambert PC, Abo-Zaid G. Metaanalysis of individual participant data: rationale, conduct, and reporting. BMJ 2010;340:c221.
25. Wagner A, Mahrholdt H, Thomson L, et al. Effects of time, dose, and inversion time for acute myocardial infarct size measurements based on magnetic resonance imaging-delayed contrast enhancement. J Am Coll Cardiol 2006; 47:2027-33.
26. Gruszczynska K, Kirschbaum S, Baks T, et al. Different algorithms for quantitative analysis of myocardial infarction with DE MRI: comparison with autopsy specimen measurements. Acad Radiol 2011;18:1529-36.
27. Eitel I, Desch S, Fuernau G, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol 2010;55:2470-9.
28. Eitel I, Kubusch K, Strohm O, et al. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevationmyocardial infarction. Circ Cardiovasc Imaging 2011;4:354-62.